Cargando…

Consistent Major Differences in Sex- and Age-Specific Diagnostic Performance among Nine Faecal Immunochemical Tests Used for Colorectal Cancer Screening

SIMPLE SUMMARY: We evaluated the performance of nine faecal immunochemical tests among participants of screening colonoscopy. A total of 216 cases of advanced neoplasia (AN, colorectal cancer or advanced adenoma) and 300 randomly selected participants without AN were included. Diagnostic performance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gies, Anton, Niedermaier, Tobias, Alwers, Elizabeth, Hielscher, Thomas, Weigl, Korbinian, Heisser, Thomas, Schrotz-King, Petra, Hoffmeister, Michael, Brenner, Hermann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306133/ https://www.ncbi.nlm.nih.gov/pubmed/34298786 http://dx.doi.org/10.3390/cancers13143574

Ejemplares similares

Fecal Immunochemical Tests Detect Screening Participants with Multiple Advanced Adenomas Better than T1 Colorectal Cancers
por: Gies, Anton, et al.
Publicado: (2021)

Variation of Positive Predictive Values of Fecal Immunochemical Tests by Polygenic Risk Score in a Large Screening Cohort
por: Niedermaier, Tobias, et al.
Publicado: (2022)

Accuracy of a fecal immunochemical test according to outside temperature and travel time
por: Niedermaier, Tobias, et al.
Publicado: (2018)

Fecal Immunochemical Tests Combined With Other Stool Tests for Colorectal Cancer and Advanced Adenoma Detection: A Systematic Review
por: Niedermaier, Tobias, et al.
Publicado: (2016)

Direct comparison of ten quantitative fecal immunochemical tests for hemoglobin stability in colorectal cancer screening
por: Gies, Anton, et al.
Publicado: (2018)

Combination of Different Fecal Immunochemical Tests in Colorectal Cancer Screening: Any Gain in Diagnostic Performance?
por: Gies, Anton, et al.
Publicado: (2019)

A single measurement of fecal hemoglobin concentration outperforms polygenic risk score in colorectal cancer risk assessment
por: Niedermaier, Tobias, et al.
Publicado: (2023)

Fecal Immunochemical Tests for Colorectal Cancer Screening: Is Fecal Sampling from Multiple Sites Necessary?
por: Amitay, Efrat L., et al.
Publicado: (2019)

Impact of Inadequate Bowel Cleansing on Colonoscopic Findings in Routine Screening Practice
por: Niedermaier, Tobias, et al.
Publicado: (2020)

Age-specific sequence of colorectal cancer screening options in Germany: A model-based critical evaluation
por: Heisser, Thomas, et al.
Publicado: (2020)

Outcomes at follow-up of negative colonoscopy in average risk population: systematic review and meta-analysis
por: Heisser, Thomas, et al.
Publicado: (2019)

The Effects of Different Invitation Schemes on the Use of Fecal Occult Blood Tests for Colorectal Cancer Screening: Systematic Review of Randomized Controlled Trials
por: Gruner, Laura F., et al.
Publicado: (2021)

Flexible sigmoidoscopy in colorectal cancer screening: implications of different colonoscopy referral strategies
por: Niedermaier, Tobias, et al.
Publicado: (2018)

Evaluation and Validation of Plasma Proteins Using Two Different Protein Detection Methods for Early Detection of Colorectal Cancer
por: Bhardwaj, Megha, et al.
Publicado: (2019)

Prevalence of Colorectal Neoplasia 10 or More Years After a Negative Screening Colonoscopy in 120 000 Repeated Screening Colonoscopies
por: Heisser, Thomas, et al.
Publicado: (2023)

Evaluation of different stool extraction methods for metabolomics measurements in human faecal samples
por: Erben, Vanessa, et al.
Publicado: (2021)

Risk Factors of Inadequate Bowel Preparation for Screening Colonoscopy
por: Amitay, Efrat L., et al.
Publicado: (2021)

Multiplex screening of 275 plasma protein biomarkers to identify a signature for early detection of colorectal cancer
por: Bhardwaj, Megha, et al.
Publicado: (2019)

Blood-Based Protein Signatures for Early Detection of Colorectal Cancer: A Systematic Review
por: Bhardwaj, Megha, et al.
Publicado: (2017)

Reproductive Factors and Colorectal Cancer Risk: A Population-Based Case-Control Study
por: Amitay, Efrat L, et al.
Publicado: (2022)

Stage-Specific Sensitivity of Fecal Immunochemical Tests for Detecting Colorectal Cancer: Systematic Review and Meta-Analysis
por: Niedermaier, Tobias, et al.
Publicado: (2020)

Impact of demographic changes and screening colonoscopy on long-term projection of incident colorectal cancer cases in Germany: A modelling study
por: Heisser, Thomas, et al.
Publicado: (2022)

When gold standards are not so golden: prevalence bias in randomized trials on endoscopic colorectal cancer screening
por: Brenner, Hermann, et al.
Publicado: (2023)

Effects of Alternative Offers of Screening Sigmoidoscopy and Colonoscopy on Utilization and Yield of Endoscopic Screening for Colorectal Neoplasms: Protocol of the DARIO Randomized Trial
por: Schrotz-King, Petra, et al.
Publicado: (2020)

Vitamin D Status, Cdx2 Genotype, and Colorectal Cancer Survival: Population-Based Patient Cohort
por: Gwenzi, Tafirenyika, et al.
Publicado: (2023)

Assessment of a Serum Microrna Risk Score for Colorectal Cancer among Participants of Screening Colonoscopy at Various Stages of Colorectal Carcinogenesis
por: Raut, Janhavi R., et al.
Publicado: (2022)

Quantitation of faecal Fusobacterium improves faecal immunochemical test in detecting advanced colorectal neoplasia
por: Wong, Sunny H, et al.
Publicado: (2017)

Utilisation of Colorectal Cancer Screening Tests in European Countries by Type of Screening Offer: Results from the European Health Interview Survey
por: Cardoso, Rafael, et al.
Publicado: (2020)

Treatment Costs of Colorectal Cancer by Sex and Age: Population-Based Study on Health Insurance Data from Germany
por: Heisser, Thomas, et al.
Publicado: (2022)

Indications of substantial delay of colorectal cancer diagnoses due to COVID-19 in Germany
por: Brenner, Hermann, et al.
Publicado: (2022)

Personalized Initial Screening Age for Colorectal Cancer in Individuals at Average Risk
por: Chen, Xuechen, et al.
Publicado: (2023)

Benefits of switching from guaiac-based faecal occult blood to faecal immunochemical testing: experience from the Wallonia–Brussels colorectal cancer screening programme
por: Guo, Feng, et al.
Publicado: (2020)

Correction: Benefits of switching from guaiac-based faecal occult blood to faecal immunochemical testing: experience from the Wallonia–Brussels colorectal cancer screening programme
por: Guo, Feng, et al.
Publicado: (2021)

Head-to-Head Comparison of the Performance of 17 Risk Models for Predicting Presence of Advanced Neoplasms in Colorectal Cancer Screening
por: Peng, Le, et al.
Publicado: (2019)

Effect of oral anticoagulants on the outcome of faecal immunochemical test
por: Bujanda, L, et al.
Publicado: (2014)

Impact of the faecal immunochemical test on colorectal cancer survival
por: Gutierrez-Stampa, María Angeles, et al.
Publicado: (2020)

Faecal immunochemical test outside colorectal cancer screening?
por: Pin-Vieito, Noel, et al.
Publicado: (2021)

Strongly Divergent Impact of Adherence Patterns on Efficacy of Colorectal Cancer Screening: The Need to Refine Adherence Statistics
por: Heisser, Thomas, et al.
Publicado: (2021)

Beyond familial risk: deriving risk‐adapted starting ages of screening among people with a family history of colorectal cancer
por: Chen, Xuechen, et al.
Publicado: (2023)

Prognostic Value of Post-Operative C-Reactive Protein-Based Inflammatory Biomarkers in Colorectal Cancer Patients: Systematic Review and Meta-Analysis
por: Gwenzi, Tafirenyika, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1de2206h0gak5q46kq9g5q6qs8